Collegium Poised To Re-Launch Nasal Spray As AllerNase In 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is also working on reformulations of Forest/Cypress’ investigational serotonin-norepinephrine reuptake inhibitor milnacipran in Phase III development for treatment of fibromyalgia.